Simple Summary Advances in lung cancer screening have led to a growing need for early
intervention strategies for the expanding cohort of patients being diagnosed with the number …

The understanding of small cell lung cancer (SCLC) biology has increased dramatically in
recent years, but the processes that allow SCLC to progress rapidly remain poorly …

Lung cancer continues to be the number one cancer killer. Despite a surge of therapeutic
advances in recent years, lung cancer remains fatal when it presents at a stage too …

The genomic and host factors that drive the progression of pre-invasive lesions in non-small
cell lung cancer are poorly understood. Studying these factors can advance our knowledge …

Lung cancer is the leading cause of cancer death for both men and women and accounts for
almost 18.4% of all deaths due to cancer worldwide, with the global incidence increasing by …

Whether single-cell RNA-sequencing (scRNA-seq) captures the same biological information
as single-nucleus RNA-sequencing (snRNA-seq) remains uncertain and likely to be context …

Non‐small cell lung cancer is a different disease from what it was a decade ago. The last 10
years were based on remarkable advances in the understanding of key genetic alterations …

Lung cancer is the leading cause of cancer-related death worldwide. Cancer
immunotherapy has shown great success in treating advanced-stage lung cancer but has …

Lung cancer is a highly heterogeneous disease. Cancer cells and cells within the tumor
microenvironment together determine disease progression, as well as response to or …

Simple Summary Lung cancer is the leading cause of cancer-related death worldwide, with
an average 5-year survival rate of approximately 15%. Among the multiple histological type …